• The document is an intimation of a scheduled Analyst/Investor Meeting, filed in compliance with SEBI LODR Regulations.
  • The event is a One to One meeting type, organized by IIFL Capital.
  • The meeting is scheduled for Thursday, August 20, 2026, in Chennai.
  • The meeting will be held in-person from 04:30 P.M. to 05:30 P.M.
  • The company note states that the meeting is "subject to changes that may happen due to exigencies on the part of Analysts/Investors of the Company."
  • A presentation for the meeting is available at the provided URL: https://d28c6jni2fmamz.cloudfront.net/8ECPQ1FY27_8dec5fbe94.pdf.
  • This disclosure will also be made available on the Company's website at www.starhealth.in.
  • The letter is signed by Jayashree Sethuraman, designated as Company Secretary & Compliance Officer.

Additional Notes Section

  • The document is a formal regulatory filing submitted to the Listing Departments of both BSE Limited and National Stock Exchange of India Limited.
  • The reference number for the filing is SHAI/B & S/SE/80/2026-27.
  • The document contains no financial data, guidance, or strategic updates. It is purely a scheduling intimation.
  • There is no explicit statement regarding the sharing of Unpublished Price Sensitive Information (UPSI) in this announcement.